Compliance & method work
Pharmacopoeia method (USP / EP / JP) with GC-UV.
USP / EP / JP-style methods with added spectral identity confirmation.
What this objective means
Pharmacopoeia methods (USP <467>, EP 2.2.46, JP equivalents) define official identity, purity and assay procedures. GC-UV runs alongside compendial GC to confirm identity beyond retention time.
Why GC-UV fits
USP/EP residual-solvent and identity tests benefit from UV confirmation of compendial peaks.
Reference
USP <467>; Eur. Ph. 2.2.46.
Recommended model
INSCAN Lab
Validated benchtop platform compatible with compendial workflows.
Typical turnaround
10–15 business days
Typical sample volume
Per compendial method
Typical matrices
Frequently asked questions
Can I add GC-UV to an existing compendial method?
Yes — GC-UV is non-destructive and runs in series with FID, so identity confirmation can be layered onto an existing method without modifying its quantitation chain.
Related in Compliance & method work
Regulatory compliance (FDA / EMA / EPA)
Add spectral identity confirmation to FDA / EMA / EPA-aligned chromatographic methods.
Method development & validation
End-to-end method development through ICH Q2(R2) validation, with documented evidence.
Method transfer / cross-lab harmonization
Transfer methods between sites without losing identity confirmation.
Routine QA/QC release testing
Identity + assay + purity in a single acquisition for routine release testing.
Ready to scope it?
